Used in research settings to quantify advanced glycation end products (AGEs) formed on hemoglobin in blood samples. This kit is particularly valuable in studies related to diabetes, where elevated levels of glycated hemoglobin are linked to long-term complications such as neuropathy, retinopathy, and cardiovascular disease. By measuring Hb-AGE, researchers can assess glycation stress and monitor the effectiveness of therapeutic interventions aimed at reducing AGE accumulation. The ELISA format allows for high sensitivity and specificity, making it suitable for both clinical research and laboratory investigations into metabolic disorders and aging-related conditions.